Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$357M |
| 2 |
NVIDIA
NVDA
|
+$317M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Trip.com Group
TCOM
|
+$192M |
| 5 |
Petrobras
PBR
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Markel Group
MKL
|
+$299M |
| 2 |
Dolby
DLB
|
+$256M |
| 3 |
JD.com
JD
|
+$128M |
| 4 |
Amazon
AMZN
|
+$117M |
| 5 |
Baidu
BIDU
|
+$83.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.93% |
| 2 | Communication Services | 18.08% |
| 3 | Healthcare | 12.56% |
| 4 | Technology | 9.19% |
| 5 | Financials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Microchip Technology
MCHP
$40.8B
| $5.3M | 0.01% |
165,320
| – | – |
|
177
Nuveen Floating Rate Income Fund
JFR
$1.24B
| $5.27M | 0.01% |
451,552
-2,298,448
| -84% | -$25.9M |
|
178
Digimarc Corp
DMRC
$161M
| $5.24M | 0.01% |
174,500
| – | – |
|
|
NVDQ
179
DELISTED
Novadaq Technologies Inc.
NVDQ
| $5M | 0.01% |
704,480
| – | – |
|
|
ONDK
180
DELISTED
On Deck Capital, Inc.
ONDK
| $4.09M | 0.01% |
884,130
-1,268,094
| -59% | -$5.93M |
|
181
Stratasys
SSYS
$706M
| $3.79M | 0.01% |
229,400
-126,700
| -36% | -$2.48M |
|
|
ADAP
182
DELISTED
Adaptimmune Therapeutics
ADAP
| $3.73M | 0.01% |
920,984
| – | – |
|
183
Wipro
WIT
$20.3B
| $3.35M | 0.01% |
1,846,053
+2,709
| +0.1% | +$4.86K |
|
|
KDNY
184
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $3.31M | 0.01% |
58,000
| – | – |
|
|
BIOA
185
DELISTED
BioAmber Inc.
BIOA
| $3.19M | 0.01% |
579,540
| – | – |
|
|
FMI
186
DELISTED
Foundation Medicine, Inc.
FMI
| $3.09M | 0.01% |
174,800
| – | – |
|
187
Rio Tinto
RIO
$156B
| $2.72M | ﹤0.01% |
70,626
| – | – |
|
188
Weibo
WB
$2.01B
| $2.48M | ﹤0.01% |
61,182
| – | – |
|
|
FOMX
189
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.44M | ﹤0.01% |
219,400
| – | – |
|
190
Acacia Research
ACTG
$447M
| $2.38M | ﹤0.01% |
365,820
| – | – |
|
|
ONC
191
BeOne Medicines Ltd
ONC
$32.6B
| $2.1M | ﹤0.01% |
69,284
+449
| +0.7% | +$14.1K |
|
192
HUTCHMED
HCM
$2.01B
| $2.09M | ﹤0.01% |
153,703
+777
| +0.5% | +$9.93K |
|
193
Regeneron Pharmaceuticals
REGN
$78.2B
| $2.02M | ﹤0.01% |
5,500
-4,600
| -46% | -$1.75M |
|
|
ATVI
194
DELISTED
Activision Blizzard
ATVI
| $1.6M | ﹤0.01% |
+44,300
| New | +$1.77M |
|
195
SK Telecom
SKM
$12.4B
| $1.2M | ﹤0.01% |
34,742
-73,853
| -68% | -$2.63M |
|
196
NetEase
NTES
$84.2B
| $283K | ﹤0.01% |
6,560
+295
| +5% | +$14.1K |
|
197
Korea Electric Power
KEP
$15.5B
| $74K | ﹤0.01% |
4,000
+2,100
| +111% | +$43.7K |
|
198
Idexx Laboratories
IDXX
$44.8B
| – | – |
-302,409
| Closed | -$34.1M |
|
199
Protalix BioTherapeutics
PLX
$187M
| – | – |
-636,136
| Closed | -$3.56M |
|
200
Televisa
TV
$1.48B
| – | – |
-2,247,243
| Closed | -$57.7M |
|
Similar funds
Baillie Gifford & Co's Q4 2016 Portfolio in Review
As of Q4 2016, Baillie Gifford & Co held 203 positions worth $60.8B, down 4.9% from $63.9B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Baillie Gifford & Co's Q4 2016 filing shows 8 new, 65 increased, 89 reduced and 5 closed positions. Its largest new stake was Petrobras: 12,394,510 shares worth $125M. The largest sale was Markel Group, an estimated $299M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q4 2016 buy was Petrobras: 12,394,510 shares worth $125M.
- Baillie Gifford & Co added most to Verisk Analytics in Q4 2016, an estimated $357M increase.
- Baillie Gifford & Co's biggest Q4 2016 reduction was Markel Group, cutting an estimated $299M.
- Baillie Gifford & Co fully exited Televisa in Q4 2016, selling an estimated $57.7M.
- Baillie Gifford & Co's ten largest holdings make up 48% of its $60.8B portfolio in Q4 2016.
- Baillie Gifford & Co opened 8 new positions and closed 5 in Q4 2016.
- Baillie Gifford & Co's portfolio value fell 4.9% quarter-over-quarter to $60.8B.
Based on Baillie Gifford & Co's 13F filing for Q4 2016, filed 14 Feb 2017.